Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis.
about
Immune responses to the enduring hypoxic response antigen Rv0188 are preferentially detected in Mycobacterium bovis infected cattle with low pathologyCorrelates of tuberculosis risk: predictive biomarkers for progression to active tuberculosisTuberculosis in elephants: antibody responses to defined antigens of Mycobacterium tuberculosis, potential for early diagnosis, and monitoring of treatmentNovel vaccination strategies against tuberculosis.Humoral response to HspX and GlcB to previous and recent infection by Mycobacterium tuberculosisTuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.Serodiagnostic efficacy of Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex, ESAT-6, and CFP-10 in patients with active tuberculosisProduction of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar.Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus.Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosisDiagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birthPotential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosisRecombinant BCG as a vaccine vehicle to protect against tuberculosis.In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen.Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from HondurasImmune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.Development of a proof of concept immunochromatographic lateral flow assay for point of care diagnosis of Mycobacterium tuberculosis.Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patientsMeasurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infectionESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients.Performance of a rapid strip test for the serologic diagnosis of latent tuberculosis in childrenDiagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.Immunodiagnosis of tuberculosis: a dynamic view of biomarker discoveryPro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.Qualitative and quantitative proteomic analysis of Vitamin C induced changes in Mycobacterium smegmatis.Construction of a Semisynthetic Human VH Single-Domain Antibody Library and Selection of Domain Antibodies against α-Crystalline of Mycobacterium tuberculosis.Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ)Regulation of inflammation by interleukin-4: a review of "alternatives"Antibody response against PhoP efficiently discriminates among healthy individuals, tuberculosis patients and their contacts.A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule.Bioinformatic and empirical analysis of novel hypoxia-inducible targets of the human antituberculosis T cell responseReproducibility of QuantiFERON-TB gold in-tube assay.
P2860
Q27334541-5F5FB99B-23AD-47F7-90B7-3384C8219143Q28077155-4AF33B4A-B3FC-4DB2-ACDB-5AFD2E2B5F2AQ28768507-164C15EB-2D40-45D6-A176-23B374009695Q30363188-D90FF007-8EF5-4769-83C9-EC5905E154CFQ33312874-5369243B-D749-49A8-91AA-DABD33138D9BQ33567995-2049BA12-7E5A-4925-AD4C-C233AE423A93Q33629397-64A08E0D-3829-4020-95B1-8ECB968F7324Q33682037-404E608E-CF31-4498-8CE5-C364A276B3EAQ33737428-043F9C3F-EA55-44A2-A1CD-54AAFA465134Q33751671-23884797-CFA9-42DC-948B-38E3C6338311Q33962683-2F83F47F-D271-415E-A350-31D6903C159EQ34133162-44DFEC27-0E34-4A69-B4F0-FDDCACCA8787Q34159493-AFEF7B85-4E48-479F-BEF9-FB1685C9151DQ34306108-7BDA55B5-3B71-41CB-A516-B8D73A7808A4Q34369813-4DBB5F84-2BAA-42C5-9E4C-F5A28D187A38Q34430676-C131B49C-92C1-439F-9428-485FEC242A7EQ34518560-698A454A-C5B2-4C04-A9D2-306A8C443B93Q34558242-F9FC3EA0-08B3-4DF0-965F-E05BA6F04B99Q34623344-6DF7FF3C-4BBF-46D0-89BE-1651BE55C8D2Q34700024-2AAE842E-2AC7-4FEC-8EDC-AB98E394EBBDQ34728874-3054208B-64EC-4E2A-9007-42BAED1E44F1Q34936752-47449E1A-AA95-47B2-8C61-1DE995B188B7Q35021144-5585C8FC-8319-4974-8B2F-FBC076FC8720Q35069386-3D2C3E22-C2DB-496D-A427-BA9306C2BB10Q35110073-355B7391-6210-40EB-AFCE-47A5CA96DDB1Q35139580-2CF951A2-F7EF-4FC5-93A3-E3517C02AE08Q35336540-586D13C7-7D6C-4029-8437-DCB195D4ECE2Q35361654-23EC0035-6038-4D5C-A4A7-0E4AA292B43DQ35514492-986F3C99-3A4F-4247-8993-36A627BCCA91Q35618056-32F259BB-2CA5-49C7-A82F-82042C4944C9Q35794080-0112F019-72F0-40D5-BDE9-447C6BE5AE03Q35840672-01079A8A-F542-4213-8CE9-0B01EC9916DFQ35913675-188C2661-BAE3-4A05-83A9-38915D66E478Q35936117-F97F4BB1-7AC0-4F80-AD6E-EFA48BC21142Q36232198-626BD342-CA2E-4C3C-8ACA-620F8BBE29B0Q36314805-B9DE7FE2-C4E1-4BDF-B6F3-9F79BD2DE3EBQ36338571-9908E72E-3067-4033-B028-433EE67F98CDQ36439241-01FF29E8-7FA8-4A5C-AFCC-86C2E620762BQ36460197-88129834-CDBD-4E58-AE43-FCB1F2051293Q36497683-EE401230-EB3D-4588-9996-0A60D20B006D
P2860
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@ast
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@en
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@nl
type
label
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@ast
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@en
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@nl
prefLabel
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@ast
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@en
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@nl
P2093
P2860
P50
P1476
Recognition of stage-specific ...... th Mycobacterium tuberculosis.
@en
P2093
Abebech Demissie
Eliane M S Leyten
Getahun Abate
Liya Wassie
Markos Abebe
Michel Klein
Philip C Hill
Roger Brookes
Sandra M Arend
T Mark Doherty
P2860
P304
P356
10.1128/CVI.13.2.179-186.2006
P577
2006-02-01T00:00:00Z